Park, J., & Cheon, J. H. (2017). Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy? Intest Res.
Styl ChicagoPark, Jihye, a Jae Hee Cheon. "Could Adalimumab Be Used Safely and Effectively in Intestinal Behçet's Disease Refractory to Conventional Therapy?" Intest Res 2017.
Citace podle MLAPark, Jihye, a Jae Hee Cheon. "Could Adalimumab Be Used Safely and Effectively in Intestinal Behçet's Disease Refractory to Conventional Therapy?" Intest Res 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..